Achema middle east

USP opens new testing facility in India

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

CMS Unveils a New Voluntary Access Programme For GLP-1

In the most recent of a string of announcements ahead...

Bevacizumab to be Used by NHS for Colorectal Cancer

NICE has gone ahead and cleared the way for...

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50...
- Advertisement -

US Pharmacopeial Convention  has opened a new expanded testing facility in the IKP Knowledge Park in Hyderabad, India. The new facility will allow voluntary testing and auditing program that helps dietary supplement manufacturers ensure and attest to the production of quality products for consumers.USP’s new facility expands its presence from 14,000 square feet to over 100,000 square feet; the number of employees will go from 70 to 90 in the coming year.

USP CEO Roger Williams said they are now poised to do more collaborative testing, verification testing, pharmacopeial education, customer support, and sourcing of written and physical standards for drugs, much of which we have been doing in concert with Indian manufacturers.

Latest stories

Related stories

CMS Unveils a New Voluntary Access Programme For GLP-1

In the most recent of a string of announcements ahead...

Bevacizumab to be Used by NHS for Colorectal Cancer

NICE has gone ahead and cleared the way for...

Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal

The French pharma giant, Sanofi, has started a $15.50...

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »